Home
/
bioAffinity Technologies, Inc.
/
Financials
/
Quarterly
bioAffinity Technologies, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that bioAffinity Technologies, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$300.2K
Nov 14, 2023
Q2
2024
Jun 30, 2023
$3.63M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$1.81M
May 15, 2024
Q3
2023
Sep 30, 2022
$1.2K
Nov 14, 2023
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.45M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$1.27M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.85M
May 15, 2025
Q3
2025
Sep 30, 2024
$2.35M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$2.40M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.41M
May 15, 2025
Q3
2024
Sep 30, 2023
$298.5K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$19.7K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$921
May 15, 2024
Q3
2023
Sep 30, 2022
$1.2K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$1.3K
Aug 14, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.05M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.06M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($2.66M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.00M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.11M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.96M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.29M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.74M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.53M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.92M)
Nov 14, 2023
Q3
2022
Jun 30, 2022
($1.56M)
Nov 14, 2022
Q2
2023
Jun 30, 2022
($88.1K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.47M)
May 15, 2023
Q3
2022
Sep 30, 2021
($1.51M)
Nov 14, 2022
Q3
2022
Jun 30, 2021
$764.3K
Nov 14, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.29M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.52M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($2.63M)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.97M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($2.09M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.95M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.29M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.78M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.56M)
May 15, 2024
Q3
2023
Sep 30, 2022
($976.2K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($684.1K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($727.0K)
May 15, 2023
Q3
2022
Sep 30, 2021
($526.3K)
Nov 14, 2022